Apollon Wealth Management’s Marrone Bio Innovations, Inc. MBII Stock Holding History

Apollon Wealth Management’s Portfolio MBII Stock Details MBII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-10,000	Closed	-$12K	–	864
2022 Q2	$12K	Hold	10,000	–	–	﹤0.01%	747
2022 Q1	$11K	Hold	10,000	–	–	﹤0.01%	755
2021 Q4	$7K	Buy	+10,000	New	+$8.09K	﹤0.01%	758

Apollon Wealth Management's MBII Position: Q3 2022 in Review

Apollon Wealth Management sold out of Marrone Bio Innovations, Inc. (MBII) in Q3 2022, closing a stake of 10,000 shares — an estimated $12K sold.

Apollon Wealth Management first reported a position in MBII in Q4 2021 and held it in 3 quarters. The position peaked at $12K in Q2 2022. 0 funds tracked by Wall St. Rank hold MBII as of Q3 2022.

Apollon Wealth Management reported no remaining Marrone Bio Innovations, Inc. position as of Q3 2022 after selling out during the quarter.
Apollon Wealth Management sold 10,000 Marrone Bio Innovations, Inc. shares in Q3 2022, an estimated $12K.
Apollon Wealth Management first reported a position in Marrone Bio Innovations, Inc. in Q4 2021 and held it in 3 quarters.
Apollon Wealth Management's Marrone Bio Innovations, Inc. position peaked at $12K in Q2 2022.
0 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q3 2022.

Based on Apollon Wealth Management's 13F filing for Q3 2022, filed 8 Nov 2022.